Table 3 Direct testing results with 20 new molecules
From: Integrative relational machine-learning for understanding drug side-effect profiles
SEP | Positives | DT | ILP | ||||
|---|---|---|---|---|---|---|---|
TP | FP | FAERS | TP | FP | FAERS | ||
SEP_1 | 4 | 0 | 5 | 1 | 2 | 3 | 1 |
SEP_2 | 11 | 1 | 2 | 1 | 0 | 1 | 1 |
SEP_3 | 2 | 0 | 3 | 1 | 0 | 5 | 1 |
SEP_4 | 3 | 0 | 3 | 1 | 1 | 2 | 1 |
SEP_5 | 5 | 0 | 2 | 1 | 1 | 2 | 1 |
SEP_6 | 5 | 1 | 5 | 3 | 2 | 3 | 1 |
SEP_7 | 15 | 2 | 2 | 1 | 2 | 1 | 1 |
SEP_8 | 4 | 1 | 1 | 1 | 1 | 3 | 1 |
SEP_9 | 3 | 0 | 3 | 2 | 0 | 3 | 1 |
SEP_10 | 5 | 0 | 1 | 0 | 0 | 3 | 1 |
SEP_11 | 4 | 1 | 3 | 2 | 1 | 3 | 1 |
SEP_12 | 0 | 0 | 5 | 1 | 0 | 4 | 1 |
SEP_13 | 4 | 0 | 6 | 2 | 1 | 4 | 1 |
SEP_14 | 4 | 1 | 0 | 0 | 1 | 5 | 2 |
SEP_15 | 1 | 0 | 2 | 1 | 0 | 5 | 2 |
SEP_16 | 3 | 0 | 6 | 2 | 2 | 7 | 3 |
SEP_17 | 1 | 0 | 5 | 3 | 0 | 2 | 1 |
SEP_18 | 2 | 0 | 3 | 1 | 0 | 2 | 1 |
SEP_19 | 1 | 0 | 4 | 2 | 0 | 5 | 2 |
SEP_20 | 3 | 0 | 3 | 1 | 1 | 4 | 1 |
SEP_21 | 8 | 1 | 2 | 1 | 1 | 2 | 1 |
SEP_22 | 5 | 0 | 3 | 1 | 1 | 5 | 1 |
SEP_23 | 3 | 0 | 3 | 1 | 1 | 4 | 1 |
SEP_24 | 5 | 1 | 4 | 2 | 2 | 5 | 2 |
SEP_25 | 8 | 0 | 3 | 2 | 2 | 5 | 2 |
SEP_26 | 4 | 0 | 6 | 3 | 0 | 3 | 1 |